Long-Acting Luteinizing Hormone-Releasing Hormone Agonist for Ovarian Hyperstimulation Induced by Tamoxifen for Breast Cancer

Tamoxifen treatment for breast cancer may induce ovarian cysts and supraphysiological levels of serum estrogen. We report successful management with luteinizing hormone-releasing hormone (LHRH) agonist of ovarian hyperstimulation induced by tamoxifen. A 49-year-old woman was operated on for invasive...

Descripción completa

Detalles Bibliográficos
Autores principales: Kojima, Nobue, Yamasaki, Yui, Koh, Houu, Miyashita, Masaru, Morita, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827888/
https://www.ncbi.nlm.nih.gov/pubmed/29607235
http://dx.doi.org/10.1155/2018/4931852

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5827888/
https://www.ncbi.nlm.nih.gov/pubmed/29607235
http://dx.doi.org/10.1155/2018/4931852

Ejemplares similares